[1]
Firman Gustina et al. 2025. How Does Metformin as First-Line Therapy Impact Long-Term Cardio- Vascular and Metabolic Outcomes in Patients with Type 2 Diabetes Mellitus over A 5-Year Period ? : A Systematic Review. The International Journal of Medical Science and Health Research. 13, 2 (Jun. 2025), 39–84. DOI:https://doi.org/10.70070/8c4yz749.